Prognostic factors for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery

N Kitasaki, Y Hamai, M Emi, T Kurokawa, T Yoshikawa… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Neoadjuvant chemotherapy (NAC) followed by surgery is a standard
treatment for patients with locally advanced esophageal cancer. This study aimed to identify …

Ability of blood cell parameters to predict clinical outcomes of nivolumab monotherapy in advanced esophageal squamous cell carcinoma

…, M Ohsawa, R Hirohata, N Kitasaki… - OncoTargets and …, 2023 - Taylor & Francis
Purpose Various blood cell parameters have been identified as predictive markers of tumor
responses and the survival of patients with cancer treated with immune checkpoint inhibitors. …

Neutrophil-to-lymphocyte ratio as a predictor of postoperative recurrence and prognosis in oesophageal squamous cell carcinoma

…, T Yoshikawa, R Hirohata, N Kitasaki… - Anticancer …, 2022 - ar.iiarjournals.org
Background: Trimodal therapy is frequently used for patients with locally advanced,
resectable oesophageal cancer. However, it does not provide a satisfactory prognosis. The …

Evaluation of neoadjuvant chemoradiotherapy followed by surgery for borderline resectable esophageal squamous cell carcinoma

…, T Yoshikawa, M Ohsawa, N Kitasaki… - World Journal of …, 2022 - Springer
Background It is occasionally difficult to diagnose cT3 or cT4b using imaging examinations
for esophageal cancer. The optimal treatment strategy for borderline resectable esophageal …

[HTML][HTML] Real-world clinical outcomes of nivolumab and taxane as a second-or later-line therapy for recurrent or unresectable advanced esophageal squamous cell …

…, T Yoshikawa, R Hirohata, N Kitasaki… - Frontiers in …, 2023 - frontiersin.org
Background Nivolumab is approved in Japan as a second-line treatment for patients with
advanced esophageal squamous cell carcinoma (ESCC) resistant to fluoropyrimidine and …

Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma

…, T Yoshikawa, R Hirohata, N Kitasaki… - Diseases of the …, 2023 - academic.oup.com
Accurate preoperative evaluation of lymph node (LN) metastasis is important for determining
the treatment strategy for superficial esophageal cancer. Blood biomarkers, such as the …

Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report

N Kitasaki, Y Hamai, T Yoshikawa, M Emi… - Thoracic …, 2022 - Wiley Online Library
Most primary esophageal adenocarcinomas arise from the Barrett epithelium of the distal
esophagus. Thus, cancer developing from the ectopic gastric mucosa (EGM) of the proximal …

The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma

…, T Kurokawa, T Yoshikawa, R Hirohata, N Kitasaki… - Surgery Today, 2024 - Springer
Purpose Various treatments are used for early postoperative recurrence of esophageal cancer,
which has a poor prognosis. We evaluated the differences in outcomes and prognoses of …

Correlation between tumor uptake on FDG-PET and malignant features in esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery

…, M Ohsawa, R Hirohata, N Kitasaki… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: To identify the correlations between the 18 F-fluorodeoxyglucose (FDG)
uptake on positron emission tomography (PET) images and the pathological features and …

Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal Cancer

…, R Hirohata, M Ohsawa, N Kitasaki… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: Surgical stress significantly decreases serum diamine oxidase (DAO), a
marker of intestinal mucosal maturation and integrity. This study aimed to determine the effects …